MoneyWorks4Me

The sales surged to Rs. 1013.36 millions, up 43.60% for the June 2026 quarter as against Rs. 705.66 millions during the corresponding quarter previous year.Net Profit for the quarter ended June 2026 zoomed to 303.16% from Rs. 79.37 millions to Rs. 319.99  millions.Operating profit surged to 385.97 millions from the corresponding previous quarter of 113.82 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1013.36 705.66 43.60 1013.36 705.66 43.60 3335.98 3457.68 -3.52
Other Income 279.62 220.36 26.89 279.62 220.36 26.89 74.53 295.81 -74.80
PBIDT 385.97 113.82 239.11 385.97 113.82 239.11 129.19 326.07 -60.38
Interest 5.16 5.55 -7.03 5.16 5.55 -7.03 26.32 4.10 541.95
PBDT 380.81 108.27 251.72 380.81 108.27 251.72 102.87 321.97 -68.05
Depreciation 22.86 23.89 -4.31 22.86 23.89 -4.31 97.63 69.69 40.09
PBT 357.95 84.38 324.21 357.95 84.38 324.21 5.24 252.28 -97.92
TAX 37.96 5.01 657.68 37.96 5.01 657.68 20.20 80.27 -74.83
Deferred Tax 25.98 5.01 418.56 25.98 5.01 418.56 -12.75 21.03 -160.63
PAT 319.99 79.37 303.16 319.99 79.37 303.16 -14.96 172.01 -108.70
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) 38.09 16.13 136.14 38.09 16.13 136.14 3.87 9.43 -58.93
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..